3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Ulnar Neuropathies
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Nurse-Patient Relations
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Capecitabine
13
Fluorouracil
12
Oxaliplatin
9
Nivolumab
9
Radiotherapy
8
Leucovorin
8
Cetuximab
8
Magnetic Resonance Spectroscopy
6
Irinotecan
5
pembrolizumab
4
encorafenib
4
Surgical Procedures, Operative
4
Sigmoidoscopy
4
Radiotherapy, Intensity-Modulated
4
Surveys and Questionnaires
3
Standard of Care
3
Specimen Handling
3
Biopsy
3
Bevacizumab
3
dostarlimab
2
dehydroftorafur
2
atezolizumab
2
XELOX
2
X-Rays
2
Observation
2
Magnetic Resonance Imaging
2
Immunoglobulin G
2
Folfox protocol
2
Drug Therapy
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Rectal Neoplasms
×
Therapeutics
×
Clear all
NCT04404777
2025-06-17
LERIS
Sahlgrenska University Hospital
Active not recruiting
12,000 enrolled